Condition: Neoplastic Disease, Solid Tumor

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT04084067

Sponsor: St. Jude Children's Research Hospital

Phase: Phase 1

Eligibility:

• Age: minimum N/A maximum N/A
• Gender: All

Inclusion Criteria:

• Patients with a primary or relapsed solid tumor or lymphoma who require excision of the tumor or metastatic lesions.

Exclusion Criteria:

• Subjects with a history of iodide allergies.
• Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
• Patients with benign pathology.
• Patients with brain tumors.
• Pregnant female.
• Patients with unilateral Wilms Tumor.

View trial on ClinicalTrials.gov